
According to this study, over the next five years the Specialty Pharmaceutical market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Specialty Pharmaceutical business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Specialty Pharmaceutical market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Specialty Pharmaceutical, covering the supply chain analysis, impact assessment to the Specialty Pharmaceutical market size growth rate in several scenarios, and the measures to be undertaken by Specialty Pharmaceutical companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Antibody
Hormone
Growth Factors
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Novartis
Roche
AbbVie
Novo Nordisk
Amgen
Merck
Johnson & Johnson
Eli Lilly
Sanofi-Aventis
Innovent
3sbio
Biotech Pharma
CP Guojian Pharmacy
Gelgen Biopharma
Changchun High Tech
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Specialty Pharmaceutical consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Specialty Pharmaceutical market by identifying its various subsegments.
Focuses on the key global Specialty Pharmaceutical manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Specialty Pharmaceutical with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Specialty Pharmaceutical submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Specialty Pharmaceutical Consumption 2015-2025
2.1.2 Specialty Pharmaceutical Consumption CAGR by Region
2.2 Specialty Pharmaceutical Segment by Type
2.2.1 Antibody
2.2.2 Hormone
2.2.3 Growth Factors
2.2.4 Other
2.3 Specialty Pharmaceutical Consumption by Type
2.3.1 Global Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
2.3.2 Global Specialty Pharmaceutical Revenue and Market Share by Type (2015-2020)
2.3.3 Global Specialty Pharmaceutical Sale Price by Type (2015-2020)
2.4 Specialty Pharmaceutical Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Other
2.5 Specialty Pharmaceutical Consumption by Application
2.5.1 Global Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
2.5.2 Global Specialty Pharmaceutical Value and Market Share by Type (2015-2020)
2.5.3 Global Specialty Pharmaceutical Sale Price by Type (2015-2020)
3 Global Specialty Pharmaceutical by Company
3.1 Global Specialty Pharmaceutical Sales Market Share by Company
3.1.1 Global Specialty Pharmaceutical Sales by Company (2018-2020)
3.1.2 Global Specialty Pharmaceutical Sales Market Share by Company (2018-2020)
3.2 Global Specialty Pharmaceutical Revenue Market Share by Company
3.2.1 Global Specialty Pharmaceutical Revenue by Company (2018-2020)
3.2.2 Global Specialty Pharmaceutical Revenue Market Share by Company (2018-2020)
3.3 Global Specialty Pharmaceutical Sale Price by Company
3.4 Global Specialty Pharmaceutical Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Specialty Pharmaceutical Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Specialty Pharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Specialty Pharmaceutical by Regions
4.1 Specialty Pharmaceutical by Regions
4.2 Americas Specialty Pharmaceutical Consumption Growth
4.3 APAC Specialty Pharmaceutical Consumption Growth
4.4 Europe Specialty Pharmaceutical Consumption Growth
4.5 Middle East & Africa Specialty Pharmaceutical Consumption Growth
5 Americas
5.1 Americas Specialty Pharmaceutical Consumption by Countries
5.1.1 Americas Specialty Pharmaceutical Consumption by Countries (2015-2020)
5.1.2 Americas Specialty Pharmaceutical Value by Countries (2015-2020)
5.2 Americas Specialty Pharmaceutical Consumption by Type
5.3 Americas Specialty Pharmaceutical Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Specialty Pharmaceutical Consumption by Regions
6.1.1 APAC Specialty Pharmaceutical Consumption by Regions (2015-2020)
6.1.2 APAC Specialty Pharmaceutical Value by Regions (2015-2020)
6.2 APAC Specialty Pharmaceutical Consumption by Type
6.3 APAC Specialty Pharmaceutical Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Specialty Pharmaceutical by Countries
7.1.1 Europe Specialty Pharmaceutical Consumption by Countries (2015-2020)
7.1.2 Europe Specialty Pharmaceutical Value by Countries (2015-2020)
7.2 Europe Specialty Pharmaceutical Consumption by Type
7.3 Europe Specialty Pharmaceutical Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Specialty Pharmaceutical by Countries
8.1.1 Middle East & Africa Specialty Pharmaceutical Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Specialty Pharmaceutical Value by Countries (2015-2020)
8.2 Middle East & Africa Specialty Pharmaceutical Consumption by Type
8.3 Middle East & Africa Specialty Pharmaceutical Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Specialty Pharmaceutical Distributors
10.3 Specialty Pharmaceutical Customer
11 Global Specialty Pharmaceutical Market Forecast
11.1 Global Specialty Pharmaceutical Consumption Forecast (2021-2025)
11.2 Global Specialty Pharmaceutical Forecast by Regions
11.2.1 Global Specialty Pharmaceutical Forecast by Regions (2021-2025)
11.2.2 Global Specialty Pharmaceutical Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Specialty Pharmaceutical Forecast by Type
11.8 Global Specialty Pharmaceutical Forecast by Application
12 Key Players Analysis
12.1 Pfizer
12.1.1 Company Information
12.1.2 Specialty Pharmaceutical Product Offered
12.1.3 Pfizer Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Novartis
12.2.1 Company Information
12.2.2 Specialty Pharmaceutical Product Offered
12.2.3 Novartis Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Novartis Latest Developments
12.3 Roche
12.3.1 Company Information
12.3.2 Specialty Pharmaceutical Product Offered
12.3.3 Roche Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Roche Latest Developments
12.4 AbbVie
12.4.1 Company Information
12.4.2 Specialty Pharmaceutical Product Offered
12.4.3 AbbVie Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 AbbVie Latest Developments
12.5 Novo Nordisk
12.5.1 Company Information
12.5.2 Specialty Pharmaceutical Product Offered
12.5.3 Novo Nordisk Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Novo Nordisk Latest Developments
12.6 Amgen
12.6.1 Company Information
12.6.2 Specialty Pharmaceutical Product Offered
12.6.3 Amgen Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Amgen Latest Developments
12.7 Merck
12.7.1 Company Information
12.7.2 Specialty Pharmaceutical Product Offered
12.7.3 Merck Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Merck Latest Developments
12.8 Johnson & Johnson
12.8.1 Company Information
12.8.2 Specialty Pharmaceutical Product Offered
12.8.3 Johnson & Johnson Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Johnson & Johnson Latest Developments
12.9 Eli Lilly
12.9.1 Company Information
12.9.2 Specialty Pharmaceutical Product Offered
12.9.3 Eli Lilly Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Eli Lilly Latest Developments
12.10 Sanofi-Aventis
12.10.1 Company Information
12.10.2 Specialty Pharmaceutical Product Offered
12.10.3 Sanofi-Aventis Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sanofi-Aventis Latest Developments
12.11 Innovent
12.11.1 Company Information
12.11.2 Specialty Pharmaceutical Product Offered
12.11.3 Innovent Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Innovent Latest Developments
12.12 3sbio
12.12.1 Company Information
12.12.2 Specialty Pharmaceutical Product Offered
12.12.3 3sbio Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 3sbio Latest Developments
12.13 Biotech Pharma
12.13.1 Company Information
12.13.2 Specialty Pharmaceutical Product Offered
12.13.3 Biotech Pharma Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Biotech Pharma Latest Developments
12.14 CP Guojian Pharmacy
12.14.1 Company Information
12.14.2 Specialty Pharmaceutical Product Offered
12.14.3 CP Guojian Pharmacy Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 CP Guojian Pharmacy Latest Developments
12.15 Gelgen Biopharma
12.15.1 Company Information
12.15.2 Specialty Pharmaceutical Product Offered
12.15.3 Gelgen Biopharma Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Gelgen Biopharma Latest Developments
12.16 Changchun High Tech
12.16.1 Company Information
12.16.2 Specialty Pharmaceutical Product Offered
12.16.3 Changchun High Tech Specialty Pharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Changchun High Tech Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Specialty Pharmaceutical Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Antibody
Table 5. Major Players of Hormone
Table 6. Major Players of Growth Factors
Table 7. Major Players of Other
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Table 10. Global Specialty Pharmaceutical Revenue by Type (2015-2020) ($ million)
Table 11. Global Specialty Pharmaceutical Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Specialty Pharmaceutical Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Table 15. Global Specialty Pharmaceutical Value by Application (2015-2020)
Table 16. Global Specialty Pharmaceutical Value Market Share by Application (2015-2020)
Table 17. Global Specialty Pharmaceutical Sale Price by Application (2015-2020)
Table 18. Global Specialty Pharmaceutical Sales by Company (2017-2019) (MT)
Table 19. Global Specialty Pharmaceutical Sales Market Share by Company (2017-2019)
Table 20. Global Specialty Pharmaceutical Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Specialty Pharmaceutical Revenue Market Share by Company (2017-2019)
Table 22. Global Specialty Pharmaceutical Sale Price by Company (2017-2019)
Table 23. Global Specialty Pharmaceutical Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Specialty Pharmaceutical Products Offered
Table 25. Specialty Pharmaceutical Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Specialty Pharmaceutical Consumption by Regions 2015-2020 (MT)
Table 27. Global Specialty Pharmaceutical Consumption Market Share by Regions 2015-2020
Table 28. Global Specialty Pharmaceutical Value by Regions 2015-2020 ($ Millions)
Table 29. Global Specialty Pharmaceutical Value Market Share by Regions 2015-2020
Table 30. Americas Specialty Pharmaceutical Consumption by Countries (2015-2020) (MT)
Table 31. Americas Specialty Pharmaceutical Consumption Market Share by Countries (2015-2020)
Table 32. Americas Specialty Pharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Specialty Pharmaceutical Value Market Share by Countries (2015-2020)
Table 34. Americas Specialty Pharmaceutical Consumption by Type (2015-2020) (MT)
Table 35. Americas Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Table 36. Americas Specialty Pharmaceutical Consumption by Application (2015-2020) (MT)
Table 37. Americas Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Table 38. APAC Specialty Pharmaceutical Consumption by Regions (2015-2020) (MT)
Table 39. APAC Specialty Pharmaceutical Consumption Market Share by Regions (2015-2020)
Table 40. APAC Specialty Pharmaceutical Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Specialty Pharmaceutical Value Market Share by Regions (2015-2020)
Table 42. APAC Specialty Pharmaceutical Consumption by Type (2015-2020) (MT)
Table 43. APAC Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Table 44. APAC Specialty Pharmaceutical Consumption by Application (2015-2020) (MT)
Table 45. APAC Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Table 46. Europe Specialty Pharmaceutical Consumption by Countries (2015-2020) (MT)
Table 47. Europe Specialty Pharmaceutical Consumption Market Share by Countries (2015-2020)
Table 48. Europe Specialty Pharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Specialty Pharmaceutical Value Market Share by Countries (2015-2020)
Table 50. Europe Specialty Pharmaceutical Consumption by Type (2015-2020) (MT)
Table 51. Europe Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Table 52. Europe Specialty Pharmaceutical Consumption by Application (2015-2020) (MT)
Table 53. Europe Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Specialty Pharmaceutical Consumption by Countries (2015-2020) (MT)
Table 55. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Specialty Pharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Specialty Pharmaceutical Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Specialty Pharmaceutical Consumption by Type (2015-2020) (MT)
Table 59. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Specialty Pharmaceutical Consumption by Application (2015-2020) (MT)
Table 61. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Table 62. Specialty Pharmaceutical Distributors List
Table 63. Specialty Pharmaceutical Customer List
Table 64. Global Specialty Pharmaceutical Consumption Forecast by Countries (2021-2025) (MT)
Table 65. Global Specialty Pharmaceutical Consumption Market Forecast by Regions
Table 66. Global Specialty Pharmaceutical Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Specialty Pharmaceutical Value Market Share Forecast by Regions
Table 68. Global Specialty Pharmaceutical Consumption Forecast by Type (2021-2025) (MT)
Table 69. Global Specialty Pharmaceutical Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Specialty Pharmaceutical Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Specialty Pharmaceutical Value Market Share Forecast by Type (2021-2025)
Table 72. Global Specialty Pharmaceutical Consumption Forecast by Application (2021-2025) (MT)
Table 73. Global Specialty Pharmaceutical Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Specialty Pharmaceutical Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Specialty Pharmaceutical Value Market Share Forecast by Application (2021-2025)
Table 76. Pfizer Product Offered
Table 77. Pfizer Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Pfizer Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 81. Novartis Product Offered
Table 82. Novartis Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 83. Novartis Main Business
Table 84. Novartis Latest Developments
Table 85. Novartis Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche Product Offered
Table 87. Roche Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Roche Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 91. AbbVie Product Offered
Table 92. AbbVie Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 93. AbbVie Main Business
Table 94. AbbVie Latest Developments
Table 95. AbbVie Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 96. Novo Nordisk Product Offered
Table 97. Novo Nordisk Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 98. Novo Nordisk Main Business
Table 99. Novo Nordisk Latest Developments
Table 100. Novo Nordisk Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 101. Amgen Product Offered
Table 102. Amgen Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 103. Amgen Main Business
Table 104. Amgen Latest Developments
Table 105. Amgen Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 106. Merck Product Offered
Table 107. Merck Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 108. Merck Main Business
Table 109. Merck Latest Developments
Table 110. Merck Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 111. Johnson & Johnson Product Offered
Table 112. Johnson & Johnson Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 113. Johnson & Johnson Main Business
Table 114. Johnson & Johnson Latest Developments
Table 115. Johnson & Johnson Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 116. Eli Lilly Product Offered
Table 117. Eli Lilly Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Eli Lilly Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 121. Sanofi-Aventis Product Offered
Table 122. Sanofi-Aventis Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 123. Sanofi-Aventis Main Business
Table 124. Sanofi-Aventis Latest Developments
Table 125. Sanofi-Aventis Basic Information, Company Total Revenue (in $ million), Specialty Pharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 126. Innovent Product Offered
Table 127. Innovent Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 128. Innovent Main Business
Table 129. Innovent Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Innovent Latest Developments
Table 131. 3sbio Product Offered
Table 132. 3sbio Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 133. 3sbio Main Business
Table 134. 3sbio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. 3sbio Latest Developments
Table 136. Biotech Pharma Product Offered
Table 137. Biotech Pharma Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 138. Biotech Pharma Main Business
Table 139. Biotech Pharma Latest Developments
Table 140. Biotech Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. CP Guojian Pharmacy Product Offered
Table 142. CP Guojian Pharmacy Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 143. CP Guojian Pharmacy Main Business
Table 144. CP Guojian Pharmacy Latest Developments
Table 145. CP Guojian Pharmacy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Gelgen Biopharma Product Offered
Table 147. Gelgen Biopharma Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 148. Gelgen Biopharma Main Business
Table 149. Gelgen Biopharma Latest Developments
Table 150. Gelgen Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Changchun High Tech Product Offered
Table 152. Changchun High Tech Specialty Pharmaceutical Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2020E)
Table 153. Changchun High Tech Main Business
Table 154. Changchun High Tech Latest Developments
Table 155. Changchun High Tech Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Specialty Pharmaceutical
Figure 2. Specialty Pharmaceutical Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Specialty Pharmaceutical Consumption Growth Rate 2015-2025 (MT)
Figure 5. Global Specialty Pharmaceutical Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Antibody
Figure 7. Product Picture of Hormone
Figure 8. Product Picture of Growth Factors
Figure 9. Product Picture of Other
Figure 10. Global Specialty Pharmaceutical Consumption Market Share by Type (2015-2020)
Figure 11. Global Specialty Pharmaceutical Value Market Share by Type (2015-2020)
Figure 12. Specialty Pharmaceutical Consumed in Tumor
Figure 13. Global Specialty Pharmaceutical Market: Tumor (2015-2020) (MT)
Figure 14. Global Specialty Pharmaceutical Market: Tumor (2015-2020) ($ Millions)
Figure 15. Specialty Pharmaceutical Consumed in Diabetes
Figure 16. Global Specialty Pharmaceutical Market: Diabetes (2015-2020) (MT)
Figure 17. Global Specialty Pharmaceutical Market: Diabetes (2015-2020) ($ Millions)
Figure 18. Specialty Pharmaceutical Consumed in Cardiovascular
Figure 19. Global Specialty Pharmaceutical Market: Cardiovascular (2015-2020) (MT)
Figure 20. Global Specialty Pharmaceutical Market: Cardiovascular (2015-2020) ($ Millions)
Figure 21. Specialty Pharmaceutical Consumed in Hemophilia
Figure 22. Global Specialty Pharmaceutical Market: Hemophilia (2015-2020) (MT)
Figure 23. Global Specialty Pharmaceutical Market: Hemophilia (2015-2020) ($ Millions)
Figure 24. Specialty Pharmaceutical Consumed in Other
Figure 25. Global Specialty Pharmaceutical Market: Other (2015-2020) (MT)
Figure 26. Global Specialty Pharmaceutical Market: Other (2015-2020) ($ Millions)
Figure 27. Global Specialty Pharmaceutical Consumption Market Share by Application (2015-2020)
Figure 28. Global Specialty Pharmaceutical Value Market Share by Application (2015-2020)
Figure 29. Global Specialty Pharmaceutical Sales Market Share by Company in 2017
Figure 30. Global Specialty Pharmaceutical Sales Market Share by Company in 2019
Figure 31. Global Specialty Pharmaceutical Revenue Market Share by Company in 2017
Figure 32. Global Specialty Pharmaceutical Revenue Market Share by Company in 2019
Figure 33. Global Specialty Pharmaceutical Sale Price by Company in 2019
Figure 34. Global Specialty Pharmaceutical Consumption Market Share by Regions 2015-2020
Figure 35. Global Specialty Pharmaceutical Value Market Share by Regions 2015-2020
Figure 36. Americas Specialty Pharmaceutical Consumption 2015-2020 (MT)
Figure 37. Americas Specialty Pharmaceutical Value 2015-2020 ($ Millions)
Figure 38. APAC Specialty Pharmaceutical Consumption 2015-2020 (MT)
Figure 39. APAC Specialty Pharmaceutical Value 2015-2020 ($ Millions)
Figure 40. Europe Specialty Pharmaceutical Consumption 2015-2020 (MT)
Figure 41. Europe Specialty Pharmaceutical Value 2015-2020 ($ Millions)
Figure 42. Middle East & Africa Specialty Pharmaceutical Consumption 2015-2020 (MT)
Figure 43. Middle East & Africa Specialty Pharmaceutical Value 2015-2020 ($ Millions)
Figure 44. Americas Specialty Pharmaceutical Consumption Market Share by Countries in 2019
Figure 45. Americas Specialty Pharmaceutical Value Market Share by Countries in 2019
Figure 46. Americas Specialty Pharmaceutical Consumption Market Share by Type in 2019
Figure 47. Americas Specialty Pharmaceutical Consumption Market Share by Application in 2019
Figure 48. United States Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 49. United States Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 50. Canada Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 51. Canada Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 52. Mexico Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 53. Mexico Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 54. APAC Specialty Pharmaceutical Consumption Market Share by Countries in 2019
Figure 55. APAC Specialty Pharmaceutical Value Market Share by Regions in 2019
Figure 56. APAC Specialty Pharmaceutical Consumption Market Share by Type in 2019
Figure 57. APAC Specialty Pharmaceutical Consumption Market Share by Application in 2019
Figure 58. China Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 59. China Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 60. Japan Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 61. Japan Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 62. Korea Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 63. Korea Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 64. Southeast Asia Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 65. Southeast Asia Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 66. India Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 67. India Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 68. Australia Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 69. Australia Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 70. Europe Specialty Pharmaceutical Consumption Market Share by Countries in 2019
Figure 71. Europe Specialty Pharmaceutical Value Market Share by Countries in 2019
Figure 72. Europe Specialty Pharmaceutical Consumption Market Share by Type in 2019
Figure 73. Europe Specialty Pharmaceutical Consumption Market Share by Application in 2019
Figure 74. Germany Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 75. Germany Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 76. France Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 77. France Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 78. UK Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 79. UK Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 80. Italy Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 81. Italy Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 82. Russia Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 83. Russia Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 84. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Countries in 2019
Figure 85. Middle East & Africa Specialty Pharmaceutical Value Market Share by Countries in 2019
Figure 86. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Type in 2019
Figure 87. Middle East & Africa Specialty Pharmaceutical Consumption Market Share by Application in 2019
Figure 88. Egypt Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 89. Egypt Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 90. South Africa Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 91. South Africa Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 92. Israel Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 93. Israel Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 94. Turkey Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 95. Turkey Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 96. GCC Countries Specialty Pharmaceutical Consumption Growth 2015-2020 (MT)
Figure 97. GCC Countries Specialty Pharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 98. Global Specialty Pharmaceutical Consumption Growth Rate Forecast (2021-2025) (MT)
Figure 99. Global Specialty Pharmaceutical Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 100. Americas Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 101. Americas Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 102. APAC Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 103. APAC Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 104. Europe Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 105. Europe Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 106. Middle East & Africa Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 107. Middle East & Africa Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 108. United States Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 109. United States Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 110. Canada Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 111. Canada Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 112. Mexico Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 113. Mexico Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 114. Brazil Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 115. Brazil Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 116. China Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 117. China Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 118. Japan Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 119. Japan Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 120. Korea Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 121. Korea Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 122. Southeast Asia Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 123. Southeast Asia Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 124. India Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 125. India Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 126. Australia Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 127. Australia Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 128. Germany Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 129. Germany Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 130. France Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 131. France Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 132. UK Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 133. UK Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 134. Italy Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 135. Italy Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 136. Russia Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 137. Russia Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 138. Spain Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 139. Spain Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 140. Egypt Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 141. Egypt Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 142. South Africa Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 143. South Africa Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 144. Israel Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 145. Israel Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 146. Turkey Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 147. Turkey Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 148. GCC Countries Specialty Pharmaceutical Consumption 2021-2025 (MT)
Figure 149. GCC Countries Specialty Pharmaceutical Value 2021-2025 ($ Millions)
Figure 150. Pfizer Specialty Pharmaceutical Market Share (2018-2020)
Figure 151. Novartis Specialty Pharmaceutical Market Share (2018-2020)
Figure 152. Roche Specialty Pharmaceutical Market Share (2018-2020)
Figure 153. AbbVie Specialty Pharmaceutical Market Share (2018-2020)
Figure 154. Novo Nordisk Specialty Pharmaceutical Market Share (2018-2020)
Figure 155. Amgen Specialty Pharmaceutical Market Share (2018-2020)
Figure 156. Merck Specialty Pharmaceutical Market Share (2018-2020)
Figure 157. Johnson & Johnson Specialty Pharmaceutical Market Share (2018-2020)
Figure 158. Eli Lilly Specialty Pharmaceutical Market Share (2018-2020)
Figure 159. Sanofi-Aventis Specialty Pharmaceutical Market Share (2018-2020)
Figure 160. Innovent Specialty Pharmaceutical Market Share (2018-2020)
Figure 161. 3sbio Specialty Pharmaceutical Market Share (2018-2020)
Figure 162. Biotech Pharma Specialty Pharmaceutical Market Share (2018-2020)
Figure 163. CP Guojian Pharmacy Specialty Pharmaceutical Market Share (2018-2020)
Figure 164. Gelgen Biopharma Specialty Pharmaceutical Market Share (2018-2020)
Figure 165. Changchun High Tech Specialty Pharmaceutical Market Share (2018-2020)
Reason to Buy